Health
COVID vaccines focus on the spike protein – but here’s another target – The Conversation UK
New research shows why the N protein might be a good target.
The latest results from the phase 3 COVID-19 vaccines trials have been very positive. These have shown that vaccinating people with the gene for SARS-CoV-2 spike protein can induce excellent protective immunity.
The spike protein is the focus of most COVID-19 vaccines as it is the part of the virus that enables it to enter our cells. Virus replication only happens inside cells, so blocking entry prevents more virus being made. If a person has antibodies that can recognise the spike protein, this…
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News16 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
Noosa News16 hours agoWest End icon closes doors
-
General18 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay